Details of the Drug Reposition

General Information of This Drug (ID: DM87P0F)

Drug Name
Carlecortemcel-L   DM87P0F
Synonyms Stemex (TN)

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2/3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Hematologic tumour DIS9Y1NR 2B33.Y Phase 2/3 [1]
Lung infection DIS5CMI0 CA4Z Phase 2/3 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT00469729) Efficacy and Safety Study of StemEx, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy. U.S. National Institutes of Health.